Elevation of serum β2-microglobulin levels may reflect the amount of tumour in patients with haematologic malignancies, particularly multiple myeloma, and have been shown to be a very effective and independent indicator of survival in multiple myeloma [10], [11]. Here, HLA-G is linked to neoplasm.